Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as
Previous Article
Pizzeria... selegnA soL ni azziP natilopae
Next Article
Destiny... metsys loS eht ot ecroF eht sg